Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Minority Interest: 2014

Historic Minority Interest for Zevra Therapeutics (ZVRA) over the last 1 years, with Dec 2014 value amounting to $24.2 million.

  • Zevra Therapeutics' Minority Interest was N/A to $28.2 million in Q1 2015 from the same period last year, while for Mar 2015 it was $28.2 million, marking a year-over-year change of. This contributed to the annual value of $24.2 million for FY2014, which is N/A change from last year.
  • As of FY2014, Zevra Therapeutics' Minority Interest stood at $24.2 million.
  • In the past 5 years, Zevra Therapeutics' Minority Interest registered a high of $24.2 million during FY2014, and its lowest value of $24.2 million during FY2014.
  • In the last 1 years, Zevra Therapeutics' Minority Interest had a median value of $24.2 million in 2014 and averaged $24.2 million.